Titre : Protéines Escherichia coli

Protéines Escherichia coli : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multicenter Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines Escherichia coli : Questions médicales les plus fréquentes", "headline": "Protéines Escherichia coli : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines Escherichia coli : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-28", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001426", "about": { "@type": "MedicalCondition", "name": "Protéines bactériennes", "code": { "@type": "MedicalCode", "code": "D001426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.097" } } }, "about": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli", "alternateName": "Escherichia coli Proteins", "code": { "@type": "MedicalCode", "code": "D029968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter L Freddolino", "url": "https://questionsmedicales.fr/author/Peter%20L%20Freddolino", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America." } }, { "@type": "Person", "name": "Lei Yin", "url": "https://questionsmedicales.fr/author/Lei%20Yin", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China." } }, { "@type": "Person", "name": "Xiaocheng Pan", "url": "https://questionsmedicales.fr/author/Xiaocheng%20Pan", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China. Electronic address: pxcpyq@sina.com." } }, { "@type": "Person", "name": "Kezong Qi", "url": "https://questionsmedicales.fr/author/Kezong%20Qi", "affiliation": { "@type": "Organization", "name": "Anhui Province Key Laboratory of Veterinary Pathobiology and Disease Control, College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, PR China. Electronic address: qkz@ahau.edu.cn." } }, { "@type": "Person", "name": "Eduardo A Ceccarelli", "url": "https://questionsmedicales.fr/author/Eduardo%20A%20Ceccarelli", "affiliation": { "@type": "Organization", "name": "Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study).", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533132", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07547-y" } }, { "@type": "ScholarlyArticle", "name": "Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.", "datePublished": "2022-11-04", "url": "https://questionsmedicales.fr/article/36333718", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12920-022-01343-4" } }, { "@type": "ScholarlyArticle", "name": "Conducting Multicenter Residency Research.", "datePublished": "2022-07-18", "url": "https://questionsmedicales.fr/article/35848055", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/08971900221116191" } }, { "@type": "ScholarlyArticle", "name": "Effect of statin use on head and neck cancer prognosis in a multicenter study using a Common Data Model.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957229", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45654-7" } }, { "@type": "ScholarlyArticle", "name": "Association between psychological vulnerability and glaucoma progression: Protocol for a multicenter prospective cohort study in South Korea.", "datePublished": "2023-10-10", "url": "https://questionsmedicales.fr/article/37816064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0292599" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001426" }, { "@type": "ListItem", "position": 5, "name": "Protéines Escherichia coli", "item": "https://questionsmedicales.fr/mesh/D029968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines Escherichia coli - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines Escherichia coli", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines Escherichia coli", "description": "Comment diagnostiquer une infection par E. coli ?\nQuels tests sont utilisés pour détecter les protéines E. coli ?\nQuels symptômes indiquent une infection par E. coli ?\nLes tests sanguins sont-ils utiles pour E. coli ?\nComment différencier E. coli des autres bactéries ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines Escherichia coli", "description": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?\nE. coli peut-elle causer des infections urinaires ?\nQuels signes indiquent une infection grave par E. coli ?\nLes symptômes d'E. coli varient selon le type ?\nComment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines Escherichia coli", "description": "Comment prévenir les infections à E. coli ?\nLes aliments crus sont-ils un risque pour E. coli ?\nLe lavage des mains réduit-il le risque d'E. coli ?\nFaut-il cuire la viande pour éviter E. coli ?\nLes voyages augmentent-ils le risque d'infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines Escherichia coli", "description": "Quel est le traitement standard pour une infection par E. coli ?\nLes antibiotiques sont-ils toujours nécessaires pour E. coli ?\nComment traiter la déshydratation due à E. coli ?\nY a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?\nLes probiotiques aident-ils après une infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines Escherichia coli", "description": "Quelles sont les complications possibles d'une infection par E. coli ?\nE. coli peut-elle causer des complications rénales ?\nComment les complications d'E. coli sont-elles traitées ?\nLes complications d'E. coli sont-elles fréquentes ?\nQuels facteurs augmentent le risque de complications par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines Escherichia coli", "description": "Quels sont les principaux facteurs de risque d'infection par E. coli ?\nLes personnes âgées sont-elles plus à risque d'E. coli ?\nLes enfants sont-ils plus vulnérables aux infections à E. coli ?\nLe système immunitaire affaibli augmente-t-il le risque d'E. coli ?\nLes voyages à l'étranger augmentent-ils le risque d'E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Multicenter+Studies+as+Topic&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par E. coli ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les protéines E. coli ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests immunologiques et des techniques de biologie moléculaire sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par E. coli ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, douleurs abdominales et parfois fièvre." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour E. coli ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent détecter des signes d'infection systémique." } }, { "@type": "Question", "name": "Comment différencier E. coli des autres bactéries ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques spécifiques et des méthodes moléculaires permettent cette différenciation." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des crampes abdominales, diarrhée sanglante et vomissements." } }, { "@type": "Question", "name": "E. coli peut-elle causer des infections urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, E. coli est une cause fréquente d'infections urinaires, provoquant douleur et brûlures." } }, { "@type": "Question", "name": "Quels signes indiquent une infection grave par E. coli ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la déshydratation sévère, la confusion ou la fièvre élevée sont préoccupants." } }, { "@type": "Question", "name": "Les symptômes d'E. coli varient selon le type ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types d'E. coli peuvent provoquer des symptômes variés, allant de légers à graves." } }, { "@type": "Question", "name": "Comment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Chez les enfants, les symptômes peuvent inclure diarrhée, vomissements et irritabilité." } }, { "@type": "Question", "name": "Comment prévenir les infections à E. coli ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne hygiène alimentaire et le lavage des mains." } }, { "@type": "Question", "name": "Les aliments crus sont-ils un risque pour E. coli ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les aliments crus, notamment la viande et les légumes, peuvent être contaminés par E. coli." } }, { "@type": "Question", "name": "Le lavage des mains réduit-il le risque d'E. coli ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un lavage des mains régulier réduit significativement le risque d'infection." } }, { "@type": "Question", "name": "Faut-il cuire la viande pour éviter E. coli ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cuire la viande à la bonne température élimine le risque d'infection par E. coli." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection par E. coli ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des régions à risque peuvent augmenter l'exposition à E. coli." } }, { "@type": "Question", "name": "Quel est le traitement standard pour une infection par E. coli ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut l'hydratation et, dans certains cas, des antibiotiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires pour E. coli ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas toujours recommandés, surtout pour les souches productrices de toxines." } }, { "@type": "Question", "name": "Comment traiter la déshydratation due à E. coli ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse." } }, { "@type": "Question", "name": "Y a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches nécessitent des traitements spécifiques basés sur leur résistance aux antibiotiques." } }, { "@type": "Question", "name": "Les probiotiques aident-ils après une infection par E. coli ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale après une infection." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par E. coli ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le syndrome hémolytique et urémique, et des infections systémiques." } }, { "@type": "Question", "name": "E. coli peut-elle causer des complications rénales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches d'E. coli peuvent entraîner des complications rénales graves." } }, { "@type": "Question", "name": "Comment les complications d'E. coli sont-elles traitées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement des complications peut nécessiter des soins intensifs et des interventions médicales." } }, { "@type": "Question", "name": "Les complications d'E. coli sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes vulnérables." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications par E. coli ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection par E. coli ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation d'aliments contaminés et le contact avec des animaux." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque d'E. coli ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections graves par E. coli." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux infections à E. coli ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Le système immunitaire affaibli augmente-t-il le risque d'E. coli ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un système immunitaire affaibli augmente le risque d'infections et de complications." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque d'E. coli ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des pays avec des normes sanitaires faibles augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study).

Venous leg ulcers (VLUs) are the most severe manifestation of chronic venous disease, with long healing time and a high recurrence rate. It imposes a heavy burden on patients, their families, and the ... This is a randomized, double-blinded, double-dummy, multi-center, placebo-controlled clinical trial. A total of 240 patients will be randomized to receive pentoxifylline (400 mg, twice daily) or place... This study would evaluate the efficacy and safety of pentoxifylline for VLUs in the Chinese population. If confirmed, it wound offer another effective and safe therapeutic option for treatment of VLUs... The trial was registered at the Chinese Clinical Trial Registry (No. ChiCTR-2100053053). Registered on 10 November, 2021, https://www.chictr.org.cn/showproj.aspx?proj=137010....

Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.

Glioblastoma (GBM), the most common glial primary brain tumour, is without exception lethal. Every year approximately 600 patients are diagnosed with this heterogeneous disease in The Netherlands. Des... The GLOW study is a prospective diagnostic cohort study executed through collaboration of the Hartwig Medical Foundation (Hartwig, a non-profit organisation) and twelve Dutch centers that perform neur... The GLOW study aims to provide the scientific evidence for changing the SOC diagnostics for patients with a recurrent glioblastoma by investigating complete genome diagnostics to maximize treatment op... ClinicalTrials.gov Identifier: NCT05186064....

Conducting Multicenter Residency Research.

Conducting well designed pharmacy resident research projects has inherent challenges including inadequate sample size, a lack of time, decreased generalizability, and inadequate research support. A wa... This article includes a general approach to conducting multicenter research from experienced individuals based upon their successes and failures. A timeline-based format is presented to lay the ground... Conducting multicenter residency research projects requires a team-based approach and advanced planning. This approach has the potential to improve pharmacy resident project quality....

Association between psychological vulnerability and glaucoma progression: Protocol for a multicenter prospective cohort study in South Korea.

Mental health is a significant concern for patients diagnosed with glaucoma, as visual impairment can have a profound impact on psychological well-being. Conversely, psychological vulnerability in gla... This study is to be a prospective multicenter study conducted at four tertiary medical centers. Patients recently diagnosed with glaucoma and not yet treated will be enrolled. Anxiety, depression, and...

A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE).

Durvalumab, a PD-L1 inhibitor, is part of an immunotherapeutic drug class shown to have prolonged survival benefit in patients with advanced stage hepatocellular carcinoma (HCC). Tivozanib is a potent...

Sexual well-being among older adults in China (SWELL): protocol for a multicenter cross-sectional study.

Existing studies on sexual health generally focus on younger populations, while the sexual well-being of older adults has received insufficient attention. This protocol describes the design of a study... We present the protocol for a multicentre observational study to investigate sexual well-being among Chinese older adults (SWELL). Eligible participants are men and women aged 50 years and older from ... This study was approved by the Human Research Ethics Committee of the School of Public Health (Shenzhen), Sun Yat-sen University (approval number SYSU-PHS[2019]006). Verbal informed consent will be ob...

Effects of the "ICU Support" team meeting concept on patient-centered and staff-centered outcomes: study protocol for a randomized controlled multicenter study.

Providing optimal care for critically ill patients is an extremely important but also highly demanding task, both emotionally and physically. The "ICU Support" team meeting concept aims to support int... ICU Support will be implemented at nine university hospitals located in Germany, following a two-arm randomized parallel group design with an intervention and a control condition and three data collec... The need for healthy and well-trained ICU staff is omnipresent; thus, structured and evidence-based interventions aimed at supporting ICU teams and facilitating patient safety are required. This multi... German Clinical Trials Register DRKS00028642 . Registered on 4 April 2022....

An analysis of the experiences of bereaved relatives and health care providers following palliative sedation: a study protocol for a qualitative international multicenter case study.

Patients at the end-of-life may experience refractory symptoms of which pain, delirium, vomiting and dyspnea are the most frequent. Palliative sedation can be considered a last resort option to allevi... This study protocol is part of the larger HORIZON 2020 Palliative Sedation project. Organisational case study methodology will be used to guide the study design. In total, 50 cases will be conducted i... The study aims to have a better understanding of the experiences of relatives and professional caregivers regarding palliative sedation and this within different settings and countries. Some limitatio...

Benefit of extending the protocol for high resolution manometry according to the version 4.0 of the Chicago criteria. A multicenter study.

The last version of the Chicago Criteria for high resolution esophageal manometry proposes an expanded protocol including complementary maneuvers to improve the diagnostic yield of the exploration. Ou... All manometry recordings performed in 4 reference centers during the first 10 months after the implementation of the new protocol were retrospectively reviewed. The time spent to complete the protocol... From a total of 756 HRM performed, 606 studies could be properly analyzed. The duration of the studies was 18.3 ± 4.3 min. From these, 11.3 ± 3.4 min were spent to complete the CCv3.0 protocol, and 7.... Prolongation of the time spent to complete the CCv4.0 protocol leads to a change in the diagnosis of 12% of patients. Clinically relevant changes are mainly related to the evaluation of EGJOO....